MedPath
TGA Approval

DUORESP SPIROMAX budesonide / formoterol fumarate dihydrate 200 microgram / 6 microgram powder for inhalation dry powder inhaler (267385)

267385

DUORESP SPIROMAX budesonide / formoterol fumarate dihydrate 200 microgram / 6 microgram powder for inhalation dry powder inhaler

Teva Pharma Australia Pty Ltd

December 19, 2016

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/56b53a038f1a9d346ee735f2915dd05d.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/ce700bc80d070485b1a3caeca333664f.pdf

Active Ingredients

budesonide

formoterol fumarate dihydrate

© Copyright 2025. All Rights Reserved by MedPath
DUORESP SPIROMAX budesonide / formoterol fumarate dihydrate 200 microgram / 6 microgram powder for inhalation dry powder inhaler (267385) - TGA 批准文号 | MedPath